Logo image of ASND

ASCENDIS PHARMA A/S - ADR (ASND) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:ASND - US04351P1012 - ADR

211.02 USD
+2.04 (+0.98%)
Last: 12/29/2025, 4:30:01 PM
211.02 USD
0 (0%)
After Hours: 12/29/2025, 4:30:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
ASND revenue by date.ASND revenue by date.
51.17M
557.71%
266.718M
421.24%
363.641M
36.34%
723.3M
98.90%
1.329B
83.74%
1.905B
43.34%
2.583B
35.59%
3.094B
19.78%
3.407B
10.12%
3.612B
6.02%
3.911B
8.28%
EBITDA
YoY % growth
ASND ebitda by date.ASND ebitda by date.
-543.86M
-24.63%
-428.796M
21.16%
-261.049M
39.12%
-99.638M
61.83%
205.69M
306.44%
796.67M
287.32%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
ASND ebit by date.ASND ebit by date.
-561.81M
-24.35%
-447.707M
20.31%
-278.763M
37.74%
-130.183M
53.30%
244.5M
287.81%
718.72M
193.96%
1.247B
73.50%
1.65B
32.32%
1.953B
18.36%
2.092B
7.12%
2.384B
13.96%
Operating Margin
ASND operating margin by date.ASND operating margin by date.
-1,097.93%-167.86%-76.66%-18.00%18.40%37.73%48.28%53.33%57.32%57.92%60.96%
EPS
YoY % growth
ASND eps by date.ASND eps by date.
-10.40
-48.36%
-8.56
17.69%
-6.57
23.25%
-3.25
50.58%
3.25
200.15%
9.05
178.39%
16.63
83.72%
21.67
30.32%
25.96
19.79%
27.38
5.46%
30.52
11.48%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
0.02
103.43%
0.32
120.51%
0.61
194.56%
0.95
194.75%
1.36
6,110.68%
Revenue
Q2Q % growth
248.11M
42.66%
276.22M
173.61%
309.85M
96.05%
343.26M
60.68%
399.53M
61.03%
EBITDA
Q2Q % growth
24.801M
37.04%
14.437M
115.67%
25.135M
157.00%
58.135M
143.56%
N/A
EBIT
Q2Q % growth
16.409M
4,184.33%
27.352M
128.28%
49.299M
193.10%
73.652M
569.75%
110.89M
575.79%

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.00
41.86%
-0.22-0.78-345.63%
Q2 2025
Q2Q % growth
-0.64
66.49%
-1.270.6349.75%
Q1 2025
Q2Q % growth
-1.58
31.30%
-1.52-0.06-3.72%
Q4 2024
Q2Q % growth
-0.64
58.44%
-0.980.3434.50%
Q3 2024
Q2Q % growth
-1.72
40.28%
-1.770.053.09%
Q2 2024
Q2Q % growth
-1.91
11.57%
-1.41-0.50-35.43%
Q1 2024
Q2Q % growth
-2.30
-16.16%
-1.53-0.77-50.09%
Q4 2023
Q2Q % growth
-1.54
58.38%
-2.070.5325.51%
Q3 2023
Q2Q % growth
-2.88
4.95%
-2.43-0.45-18.71%
Q2 2023
Q2Q % growth
-2.16
-47.95%
-2.640.4818.26%
Q1 2023
Q2Q % growth
-1.98
10.41%
-2.710.7327.04%
Q4 2022
Q2Q % growth
-3.70
-97.86%
-2.61-1.09-41.66%
Q3 2022
Q2Q % growth
-3.03
-106.12%
-2.54-0.49-19.31%
Q2 2022
Q2Q % growth
-1.46
41.60%
-2.170.7132.87%
Q1 2022
Q2Q % growth
-2.21
-88.89%
-2.04-0.17-8.34%
Q4 2021
Q2Q % growth
-1.87
29.17%
-2.390.5221.73%
Q3 2021
Q2Q % growth
-1.47
36.36%
-2.340.8737.16%
Q2 2021
Q2Q % growth
-2.50
-26.90%
-2.27-0.23-10.14%
Q1 2021
Q2Q % growth
-1.17
11.36%
-1.740.5732.73%
Q4 2020
Q2Q % growth
-2.64
-55.29%
-1.58-1.06-66.91%
Q3 2020
Q2Q % growth
-2.31
-335.85%
-1.61-0.70-43.80%
Q2 2020
Q2Q % growth
-1.97
-57.60%
-1.48-0.49-32.97%
Q1 2020
Q2Q % growth
-1.32
-6.45%
-1.380.064.01%
Q4 2019
Q2Q % growth
-1.70 -1.49-0.21-14.18%
Q3 2019
Q2Q % growth
-0.53 -1.210.6856.30%
Q2 2019
Q2Q % growth
-1.25 -1.23-0.02-1.41%
Q1 2019
Q2Q % growth
-1.24 -1.02-0.22-21.37%
ASND Yearly EPS VS EstimatesASND Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 -10 20 30
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
213.634M
269.40%
218.08M-4.446M-2.04%
Q2 2025
Q2Q % growth
158.045M
339.04%
144.38M13.665M9.46%
Q1 2025
Q2Q % growth
100.954M
5.28%
96.537M4.417M4.58%
Q4 2024
Q2Q % growth
173.916M
26.30%
122.1M51.816M42.44%
Q3 2024
Q2Q % growth
57.833M
20.40%
84.011M-26.178M-31.16%
Q2 2024
Q2Q % growth
35.998M
-24.04%
85.651M-49.653M-57.97%
Q1 2024
Q2Q % growth
95.894M
185.49%
81.081M14.813M18.27%
Q4 2023
Q2Q % growth
137.703M
501.32%
64.385M73.318M113.87%
Q3 2023
Q2Q % growth
48.034M
214.15%
49.077M-1.043M-2.13%
Q2 2023
Q2Q % growth
47.393M
669.37%
38.097M9.296M24.40%
Q1 2023
Q2Q % growth
33.589M
391.79%
21.956M11.633M52.98%
Q4 2022
Q2Q % growth
22.9M
367.35%
20.233M2.667M13.18%
Q3 2022
Q2Q % growth
15.29M
1,277.48%
9.062M6.228M68.73%
Q2 2022
Q2Q % growth
6.16M
503.92%
5.927M233K3.93%
Q1 2022
Q2Q % growth
6.83M
810.67%
4.766M2.064M43.31%
Q4 2021
Q2Q % growth
4.9M
807.41%
2.712M2.188M80.68%
Q3 2021
Q2Q % growth
1.11M
-59.78%
1.16M-50K-4.31%
Q2 2021
Q2Q % growth
1.02M
-29.17%
862.41K157.59K18.27%
Q1 2021
Q2Q % growth
750K
-66.37%
1.917M-1.167M-60.88%
Q4 2020
Q2Q % growth
540K
-78.49%
1.709M-1.169M-68.40%
Q3 2020
Q2Q % growth
2.76M
23.21%
1.426M1.334M93.55%
Q2 2020
Q2Q % growth
1.44M
-55.14%
2.23M-790K-35.43%
Q1 2020
Q2Q % growth
2.23M
-58.78%
1.89M340K17.99%
Q4 2019
Q2Q % growth
2.51M 1.372M1.138M82.94%
Q3 2019
Q2Q % growth
2.24M 809.37K1.431M176.76%
Q2 2019
Q2Q % growth
3.21M 258.397K2.952M1,142.28%
Q1 2019
Q2Q % growth
5.41M 377.4K5.033M1,333.49%
ASND Yearly Revenue VS EstimatesASND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-74.41% 157.15% -35.23% -21.62%
Revenue-0.87% -6.98% -2.96% -1.68%